Friday 6 November 2026 Export LMAT’s income statement to Excel — free account

LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.

Revenue: +11.3%
EPS: −14.3%
Free cash flow: −25.8%
Total debt: +0.53%

Quarter to September 2026, against a year earlier

80.99 2.50 −2.99%

Follow LMAT

Alert me

Market cap: $1.9B
P/E: 29.7×
Fwd P/E: 28.2×
Dividend yield: 1.15%
F-score: 6/9
Altman Z: 6.99
Beneish M: −2.61
Dividend safety: 93/100

Overview

LeMaitre Vascular, Inc. (LMAT) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, LeMaitre Vascular, Inc. (LMAT) trades at a P/S ratio of 7.0×. Over the past ten years it has ranged from 1.7× (January 2015) to 11.4× (November 2024); the current reading is higher than 65% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LMAT/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="LeMaitre Vascular, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LMAT/metrics/ps-ratio">LeMaitre Vascular, Inc. (LMAT) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	7.4×	(21.83%)
FY2024	9.4×	44.49%
FY2023	6.5×	5.44%
FY2022	6.2×	(10.26%)
FY2021	6.9×	8.57%
FY2020	6.3×	4.32%
FY2019	6.1×	39.67%
FY2018	4.4×	(25.64%)
FY2017	5.8×	11.82%
FY2016	5.2×	33.76%

Period	P/S ratio	Change
Sep 2026	7.0×	(16.10%)
Jun 2026	8.4×	(13.95%)
Mar 2026	9.7×	32.05%
Dec 2025	7.4×	(10.66%)
43 more quarters	Free account

Against its own ten years

Low 1.7× High 11.4×

Ten-year median 6.4×

Current reading's percentile 61

Company	P/S ratio
XRAY DENTSPLY SIRONA Inc. compare	0.6×
STVN Stevanato Group S.p.A. compare	2.5×
AZTA Azenta, Inc. compare	2.8×
WRBY Warby Parker Inc. compare	3.5×
STAA STAAR Surgical Company compare	4.1×
ATRC AtriCure, Inc. compare	5.0×
LMAT LeMaitre Vascular, Inc.	7.0×
KMTS Kestra Medical Technologies, Ltd. compare	15.3×
PLSE Pulse Biosciences, Inc compare	2,559×
Medical Instruments & Supplies industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

LeMaitre Vascular, Inc. (LMAT) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on LMAT

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on LMAT

Stockrow Weekly